Companies in #Interventional Oncology
Found 2 companies operating in this sector.
AngioDynamics, Inc. is a medical technology company that designs, manufactures and sells medical, surgical and diagnostic devices used to treat peripheral vascular disease and in oncology and surgical settings. Its portfolio includes the Auryon Atherectomy System, the AlphaVac and AngioVac thrombus-management platforms, the NanoKnife irreversible electroporation (IRE) ablation system, the Solero Microwave Tissue Ablation System and the VenaCure EVLT endovenous laser system. The company reported fiscal first-quarter 2027 results on October 8, 2026, beating on both adjusted EPS and revenue.
Profound Medical Corp. is a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image-guided ablation of diseased tissue. Its lead product, TULSA-PRO, combines real-time MRI, robotically driven transurethral ultrasound and closed-loop temperature feedback to ablate physician-defined regions of the prostate, and its Sonalleve platform combines real-time MRI thermometry for the treatment of uterine fibroids, adenomyosis, palliative bone-metastasis pain and benign tumours. The company reported preliminary third-quarter 2026 revenue of $9.8–10.0 million, roughly 45–47% above analyst consensus.